Marti Boss

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Sex Differences in [ 68Ga]Ga-NODAGA-Exendin-4 Uptake in the Pituitary of Individuals With Type 2 Diabetes.

Sex Differences in [ 68Ga]Ga-NODAGA-Exendin-4 Uptake in the Pituitary of Individuals With Type 2 Diabetes.

Journal: Diabetes, obesity & metabolism

Published: December 03, 2025

Structural determinants of beta-cell failure in type 2 diabetes: a multimodality imaging study.

Structural determinants of beta-cell failure in type 2 diabetes: a multimodality imaging study.

Journal: Metabolism: clinical and experimental

Published: November 12, 2025

Beta cell function and mass in individuals with and without remission of type 2 diabetes after Roux-en-Y gastric bypass.

Beta cell function and mass in individuals with and without remission of type 2 diabetes after Roux-en-Y gastric bypass.

Journal: Diabetologia

Published: July 10, 2025

β-Cell Mass in Individuals With and Without Postbariatric Hypoglycemia After Roux-en-Y Gastric Bypass.

β-Cell Mass in Individuals With and Without Postbariatric Hypoglycemia After Roux-en-Y Gastric Bypass.

Journal: Diabetes

Published: June 20, 2025

[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism.

[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism.

Journal: EJNMMI research

Published: September 02, 2024

Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT.

Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 14, 2024

Activation of the HPA Axis Does Not Explain Nonresponsiveness to GLP-1R Agonist Treatment in Individuals With Type 2 Diabetes.

Activation of the HPA Axis Does Not Explain Nonresponsiveness to GLP-1R Agonist Treatment in Individuals With Type 2 Diabetes.

Journal: Diabetes

Published: June 04, 2024

Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas.

Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas.

Journal: EJNMMI research

Published: December 15, 2023

Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia.

Impact of tyrosine kinase inhibitors on glucose control and insulin regulation in patients with chronic myeloid leukemia.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 25, 2023

Protocol for Clinical GLP-1 Receptor PET/CT Imaging with [68Ga]Ga-NODAGA-Exendin-4.

Protocol for Clinical GLP-1 Receptor PET/CT Imaging with [68Ga]Ga-NODAGA-Exendin-4.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 12, 2022

Monitoring β-Cell Survival After Intrahepatic Islet Transplantation Using Dynamic Exendin PET Imaging: A Proof-of-Concept Study in Individuals With Type 1 Diabetes.

Monitoring β-Cell Survival After Intrahepatic Islet Transplantation Using Dynamic Exendin PET Imaging: A Proof-of-Concept Study in Individuals With Type 1 Diabetes.

Journal: Diabetes

Published: October 25, 2022

Importance of beta cell mass for glycaemic control in people with type 1 diabetes.

Importance of beta cell mass for glycaemic control in people with type 1 diabetes.

Journal: Diabetologia

Published: June 29, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026